1Lai CL,RatziuV,Yuen MF,et al. Viral hepatitis B. Lancet, 2003,362:2089-2094.
2Yu Wang,Jidong Jia: Control of hepatitis B in China: prevention and treatment. Expert Rev Anti Infect Ther,2011,9(1):21-25.
3Marazzi MG,Gigliotti AR,Bondi E,et al. Clinical outcome of chronic hepatitis B in children during a long term follow-up. Ital J Pediatr ,2002,28:128-132.
4Bortolotti F,Wirth S,Crivellaro C,et al. Long term persistence of hepatitis B virus DNA in the serum of children with chronic hepatitis B after hepatitis B e antigen to antibody seroconversion J Pediatr Gastroenterol Nutr, 1996,22(3):270-274.
6M ozer-Lisewska I, Mania A, Sluzewski W.Factors influencing clinical course and histological findings in children with chronic hepatitis B. Eur J Gastroenterol Hepatol,2009,21 ( 12):1400-1406.
7Jonas MM,Block JM,Haher BA,et al. Treatment of children with chronic hepatitis B virus infection in the United States: patient selection and therapeutic options. Hepatology,2001,52 ( 6 ):2192-2205.
8Shah U, Kelly D, Chang MH, et al. Management of chronic hepatitis B in children. J Pediatr Gastroenterol Nutr,2009,48 (4):399-404.
9Heller S,Valencia-Mayoral P. Treatment of viral hepatitis in children. Arch Med Res,2007,38(6):702-710.
10Kuloglu Z,Kirbas G,Erden E,et al. Interferon-alpha-2a and zinc combination therapy in children with chronic hepatitis B infection. Bid Trace Elem Res,2011,143(3):1302-1309.
